NYSE:CRL Charles River Laboratories International (CRL) Earnings Date, Estimates & Call Transcripts $201.58 +2.47 (+1.24%) (As of 06/6/2023 ET) Add Compare Share Share Today's Range$198.51▼$202.6550-Day Range$183.71▼$208.5552-Week Range$181.22▼$262.00Volume324,196 shsAverage Volume560,422 shsMarket Capitalization$10.32 billionP/E Ratio20.85Dividend YieldN/APrice Target$260.73 EarningsProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCRL Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CRL Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.Charles River Laboratories International Analyst ForecastsQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany GuidanceQ1 20233$2.54$2.79$2.64 Q2 20233$2.47$3.11$2.72 Q3 20233$2.24$2.96$2.51 Q4 20233$2.41$2.53$2.47 FY 202312$9.66$11.39$10.34 Q1 20242$2.81$2.82$2.82 Q2 20242$2.94$2.99$2.97 Q3 20242$2.69$3.06$2.88 Q4 20242$2.74$3.22$2.98 FY 20248$11.18$12.09$11.64 Q1 20251$3.61$3.61$3.61 Get Charles River Laboratories International Earnings AlertsEnter your email address below to receive the latest news and earnings results for CRL and its competitors with MarketBeat's FREE daily newsletter. CRL Earnings Date and InformationCharles River Laboratories International has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 2nd, 2023 based off prior year's report dates.Read More Charles River Laboratories International Earnings History by Quarter Export to ExcelDateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 8/2/2023(Estimated) 2/22/2023Q4 2022$2.75$2.98+$0.23$2.31$1.04 billion$1.10 billion 11/2/2022Q3 2022$2.51$2.63+$0.12$3.38$978.65 million$989.16 million8/3/2022Q2 2022$2.74$2.77+$0.03$3.41$995.12 million$973.13 million 5/4/2022Q1 2022$2.71$2.75+$0.04$3.69$908.64 million$913.93 million 2/16/2022Q4 2021$2.42$2.49+$0.07$2.31$888.27 million$905.05 million 11/2/20219/30/2021$2.58$2.70+$0.12$3.39$902.03 million$895.90 million 8/3/20216/30/2021$2.38$2.61+$0.23$3.50$880.72 million$914.61 million 5/3/20213/31/2021$2.19$2.53+$0.34$3.86$798.52 million$824.60 million 2/16/202112/31/2020$2.11$2.39+$0.28$1.97$755.98 million$790.99 million 10/29/20209/30/2020$1.80$2.33+$0.53$2.63$715.63 million$743.30 million 8/5/20206/30/2020$1.27$1.58+$0.31$1.82$638.70 million$682.60 million 5/7/20203/31/2020$1.46$1.84+$0.38$2.66$692.11 million$707.06 million 2/11/2020Q4 2019$1.83$2.01+$0.18$2.41$685.46 million$691.10 million 11/6/20199/30/2019$1.64$1.69+$0.05$1.92$674.08 million$668.00 million 7/31/2019Q2$1.55$1.63+$0.08$2.38$662.61 million$657.60 million 5/7/20193/31/2019$1.38$1.40+$0.02$1.69$587.65 million$604.57 million 2/13/201912/31/2018$1.39$1.49+$0.10$1.77$589.86 million$605.53 million 11/7/20189/30/2018$1.38$1.53+$0.15$1.84$567.58 million$585.30 million 8/8/2018Q2 2018$1.46$1.62+$0.16$2.14$570.65 million$585.30 million 5/10/2018Q1 2018$1.26$1.38+$0.12$1.68$480.03 million$493.97 million 2/13/2018Q4 2017$1.26$1.40+$0.14$3.43$475.02 million$478.50 million 11/9/2017Q3 2017$1.22$1.30+$0.08$1.52$458.93 million$464.23 million8/9/2017Q2 2017$1.22$1.29+$0.07$1.46$458.25 million$469.13 million 5/10/2017Q1 2017$1.1420$1.29+$0.1480$1.61$437.04 million$445.80 million2/14/2017Q416$1.11$1.21+$0.10$1.49$441.64 million$466.80 million 11/2/2016Q316$1.13$1.18+$0.05$1.57$291.20 million$425.70 million 8/3/2016Q216$1.10$1.20+$0.10$1.67$425.05 million$434.10 million 5/4/2016Q116$0.90$0.98+$0.08$1.18$354.92 million$354.90 million 2/10/2016Q415$0.94$1.00+$0.06$1.33$349.20 million$353.90 million 11/4/2015Q315$0.94$1.03+$0.09$1.27$340.09 million$349.50 million 7/30/2015Q215$0.97$0.96($0.01)$0.90$338.30 million$339.60 million 4/29/2015Q115$0.82$0.79($0.03)$0.92$324.00 million$320.40 million 2/10/2015Q414$0.71$0.81+$0.10$1.05$318.73 million$329.50 million 10/29/2014Q314$0.80$0.86+$0.06$1.04$326.70 million$327.60 million 8/6/2014Q214$0.82$0.97+$0.15$1.20$327.96 million$341.18 million 4/30/2014Q114$0.74$0.82+$0.08$0.97$302.08 million$299.40 million 2/11/2014Q4 2013$0.68$0.73+$0.05$1.06$289.56 million$289.20 million 10/29/2013Q3 2013$0.70$0.79+$0.09$0.94$290.28 million$292.10 million 7/31/2013Q2 2013$0.71$0.73+$0.02$0.90$293.77 million$294.40 million 5/1/2013Q1 2013$0.71$0.69($0.02)$0.85$294.53 million$291.20 million 2/13/2013Q4 2012$0.60$0.64+$0.04$280.81 million$280.10 million 10/30/2012$0.62$0.65+$0.03 8/7/2012$0.66$0.75+$0.095/2/2012$0.65$0.70+$0.05 2/13/2012$0.56$0.69+$0.13 11/1/2011$0.58$0.57($0.01)8/2/2011$0.60$0.70+$0.105/3/2011$0.55$0.61+$0.062/8/2011$0.50$0.60+$0.1011/3/2010Q3 2010$0.49$0.45($0.04)$1.308/2/2010Q2 2010$0.50$0.49($0.01)$0.764/26/2010Q1 2010$0.47$0.45($0.02)$0.642/8/2010Q4 2009$0.43$0.49+$0.06$0.7111/3/2009Q3 2009$0.60$0.65+$0.05$0.738/4/2009Q2 2009$0.58$0.66+$0.08$0.805/5/2009Q1 2009$0.53$0.58+$0.05$0.782/9/2009Q4 2008$0.55$0.59+$0.04$11.0911/5/2008Q3 2008$0.74$0.76+$0.02$0.898/5/2008Q2 2008$0.73$0.79+$0.06$0.875/6/2008Q1 2008$0.68$0.72+$0.04$0.802/11/2008Q4 2007$0.64$0.65+$0.01$0.78Charles River Laboratories International Earnings - Frequently Asked Questions When is Charles River Laboratories International's earnings date? Charles River Laboratories International has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 2nd, 2023 based off last year's report dates. Learn more on CRL's earnings history. How much revenue does Charles River Laboratories International generate each year? Charles River Laboratories International (NYSE:CRL) has a recorded annual revenue of $3.98 billion. How much profit does Charles River Laboratories International generate each year? Charles River Laboratories International (NYSE:CRL) has a recorded net income of $486.23 million. CRL has generated $9.67 earnings per share over the last four quarters. What is Charles River Laboratories International's price-to-earnings ratio? Charles River Laboratories International (NYSE:CRL) has a trailing price-to-earnings ratio of 20.85 and a forward price-to-earnings ratio of 19.57. The price/earnings-to-growth ratio is 1.39. What is Charles River Laboratories International's EPS forecast for next year? Charles River Laboratories International's earnings are expected to grow from $10.30 per share to $11.90 per share in the next year, which is a 15.53% increase. More Earnings Resources from MarketBeat Related Companies: MEDP Earnings Results INCY Earnings Results SYNH Earnings Results ICLR Earnings Results APLS Earnings Results SWAV Earnings Results QGEN Earnings Results HSIC Earnings Results RGEN Earnings Results UTHR Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Trading Channel Breakout in Lululemon Brought by EarningsNordstrom's Earnings Beat, A Rally In The MakingMacy's Stock Earnings, A Pivotal StoryC3.AI's Lukewarm Earnings: Failing to Cash in on AI Boom?NetApp Is Gearing Up To Breakout After Earnings Top EstimatesWhat U-Haul Earnings Are Showing, Heading Up?Can Earnings Narrow The Value Gap In Hewlett Packard? This page (NYSE:CRL) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Charles River Laboratories International, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.